A prospective study of infections in penetrating abdominal trauma.
D000005:Abdomen / Q000601:surgery; D000007:Abdominal Injuries / Q000382:microbiology*; D000693:Anaerobiosis; D001439:Bacteroides; D001769:Blood / Q000382:microbiology; D002512:Cephalothin / Q000627:therapeutic use; D002641:Chicago; D002981:Clindamycin / Q000627:therapeutic use; D003013:Clostridium; D005051:Eubacterium; D005260:Female; D006801:Humans; D007420:Intestine, Large / Q000293:injuries; D007421:Intestine, Small / Q000293:injuries; D007422:Intestines / Q000293:injuries* / Q000382:microbiology; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D010462:Peptostreptococcus; D011424:Propionibacterium; D011446:Prospective Studies; D011549:Pseudomonas; D013183:Sputum / Q000382:microbiology; D014556:Urine / Q000382:microbiology; D014946:Wound Infection / Q000188:drug therapy
D002981:Clindamycin; D007612:Kanamycin; D002512:Cephalothin